Entrada Therapeutics
Price & Volume
Stats
See more52W Range | $11.35-$21.79 |
Market Cap | $658.2M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $215.2M |
Revenue Growth (YoY) | -55.3% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $1.44 |
News
See moreYahoo Finance • last year
Entrada Therapeutics Announces Updates on ENTR-601-44 in Duchenne Muscular Dystrophy
Yahoo Finance • last year
Entrada Therapeutics Reports Third Quarter 2023 Financial Results
Yahoo Finance • last year
Entrada Therapeutics to Present at Upcoming Investor Conferences
Yahoo Finance • 2 years ago
Entrada Therapeutics Reports First Quarter 2023 Financial Results
About
CEO | Mr. Dipal Doshi |
CFO | Mr. Kory James Wentworth CPA |
Address | One Design Center Place, Boston, MA, United States, 02210 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 177 |
